Fri, February 3, 2023

Matthew Biegler Initiated (TYRA) at Buy and Held Target at $17 on, Feb 3rd, 2023

Matthew Biegler of Oppenheimer, Initiated "Tyra Biosciences, Inc." (TYRA) at Buy and Held Target at $17 on, Feb 3rd, 2023.

Matthew, nor any peers, have made any analyst calls on TYRA in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30